MyChild’sCancer pioneering initiative combines the efforts of expert committees and personalized treatment research to empower families in their quest to provide the best possible care for their children facing pediatric cancer. Our dedicated team of cancer experts and researchers works tirelessly to connect families with tailored, most current treatment options, significantly enhancing the chances of survival and all-around better outcomes for young patients.

At the heart of MyChild'sCancer are our international committees of experts, each specializing in a specific type of pediatric cancer. These committees, which include the Brain Tumor Committee, Solid Tumor Committee, Neuroblastoma Committee, and more, comprise world-renowned specialists from the USA, Canada, Italy, Germany, the UK, and beyond. They join forces to cover every aspect of these challenging cancers, ensuring families and local doctors have access to the latest treatment insights and best practices.

MyChild’sCancer (MCC) offers parents and treating doctors direct access to the world's foremost cancer experts. This access includes a comprehensive review of the child's complete medical file, personalized expert second opinions, and telehealth sessions. During these sessions, our specialists share the most current treatment options, ensuring that parents and caregivers are well-informed and supported throughout their child's journey.

MyChild'sCancer is committed to supporting families.  Our ultimate goal is to enable parents to be informed about the most effective treatments available for their child so they can make informed decisions about their child's care. We do this by providing them with access to life-saving information and facilitating the best possible care for children facing these challenging cancers. By combining the expertise of international committees with personalized treatment research, we aim to make a profound difference in the lives of young cancer patients and their families.